ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 10/10/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. JAGX, SHPH, ENVB, ADXS, INDP, TRIB, REVB, ADTX, ARTL, and DRMAShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Jaguar Animal Health (JAGX), Shuttle Pharmaceuticals (SHPH), Enveric Biosciences (ENVB), Ayala Pharmaceuticals (ADXS), Indaptus Therapeutics (INDP), Trinity Biotech (TRIB), Revelation Biosciences (REVB), Aditxt (ADTX), Artelo Biosciences (ARTL), and Dermata Therapeutics (DRMA). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Its Competitors Jaguar Animal Health Shuttle Pharmaceuticals Enveric Biosciences Ayala Pharmaceuticals Indaptus Therapeutics Trinity Biotech Revelation Biosciences Aditxt Artelo Biosciences Dermata Therapeutics ASLAN Pharmaceuticals (NASDAQ:ASLN) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings. Is ASLN or JAGX more profitable? ASLAN Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -344.16%. Jaguar Animal Health's return on equity of -660.18% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Jaguar Animal Health -344.16%-660.18%-77.42% Do insiders & institutionals have more ownership in ASLN or JAGX? 58.8% of ASLAN Pharmaceuticals shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are held by insiders. Comparatively, 4.6% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, ASLN or JAGX? Jaguar Animal Health has lower revenue, but higher earnings than ASLAN Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Jaguar Animal Health$11.81M0.39-$38.49MN/AN/A Does the media favor ASLN or JAGX? In the previous week, Jaguar Animal Health had 2 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 2 mentions for Jaguar Animal Health and 0 mentions for ASLAN Pharmaceuticals. Jaguar Animal Health's average media sentiment score of 0.64 beat ASLAN Pharmaceuticals' score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the news media. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Jaguar Animal Health Positive Do analysts recommend ASLN or JAGX? Jaguar Animal Health has a consensus target price of $60.00, suggesting a potential upside of 2,716.90%. Given Jaguar Animal Health's stronger consensus rating and higher probable upside, analysts plainly believe Jaguar Animal Health is more favorable than ASLAN Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASLAN Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, ASLN or JAGX? ASLAN Pharmaceuticals has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Jaguar Animal Health has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. SummaryJaguar Animal Health beats ASLAN Pharmaceuticals on 9 of the 14 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$1.00B$6.04B$10.44BDividend YieldN/A4.84%5.73%4.79%P/E Ratio-0.031.2885.3127.07Price / Sales0.1031.05588.57190.17Price / CashN/A17.6425.7330.17Price / Book-0.097.5412.666.69Net Income-$44.22M-$7.59M$3.31B$276.03M7 Day PerformanceN/A-1.36%-0.44%-1.13%1 Month PerformanceN/A18.72%8.70%6.49%1 Year PerformanceN/A-10.20%76.70%34.41% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330JAGXJaguar Animal Health2.1731 of 5 stars$2.13-2.7%$60.00+2,716.9%-93.4%$4.63M$11.81M0.0050SHPHShuttle Pharmaceuticals0.7091 of 5 stars$4.20-2.6%N/A-85.4%$4.49MN/A-1.015ENVBEnveric Biosciences2.1199 of 5 stars$0.70+0.5%$10.00+1,336.2%-90.1%$4.31MN/A-0.0220ADXSAyala PharmaceuticalsN/A$0.10flatN/A+88.9%$4.25M$3.24M-0.0120INDPIndaptus Therapeutics2.1136 of 5 stars$3.69+15.7%$238.00+6,349.9%-89.0%$4.10MN/A-0.106Gap UpHigh Trading VolumeTRIBTrinity Biotech1.4923 of 5 stars$1.07-3.2%N/A-89.5%$3.82M$61.56M-0.07480REVBRevelation Biosciences1.5926 of 5 stars$1.46+2.1%N/A-96.4%$3.42MN/A-0.0210Positive NewsADTXAditxtN/A$0.66-3.4%N/A-99.8%$3.30M$12.05K0.0060Gap UpARTLArtelo Biosciences2.9723 of 5 stars$4.36-2.9%$24.00+450.5%-32.3%$3.07MN/A-0.235DRMADermata Therapeutics2.7672 of 5 stars$4.48-16.7%$10.00+123.2%-69.3%$3.05MN/A-0.278Gap DownHigh Trading Volume Related Companies and Tools Related Companies JAGX Alternatives SHPH Alternatives ENVB Alternatives ADXS Alternatives INDP Alternatives TRIB Alternatives REVB Alternatives ADTX Alternatives ARTL Alternatives DRMA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
